Zephyrnet Logo

Generative Data Intelligence

Tag: Biopharma

Daiichi’s biotech unit Plexxikon snaps up BRAF cancer drug from Novellus

Biotechnology
Cancer biotech Novellus has struck a deal with Plexxikon for its early- to midstage BRAF-inhibiting hopeful PLX8394. Little-known Novellus is licensing the drug,...

In conversation with Tom Lynch, president and director of Fred Hutchinson Cancer Research Center

Biotechnology
From chief scientific officer of Bristol Myers Squibb to running one of the biggest cancer research organizations in the world is a major...

Keensight taps biopharma, medical experts as newest operating partners

Private Equity
European private equity house Keensight Capital has brought in a pair of medical and biopharma industry experts as its n Sorry, you need to...

AI Drug Discovery Firm Exscientia Closes €54M Series C

AI
UK-based Exscientia has closed a Series C financing round of €54M ($60M) to develop its artificial intelligence (AI) technology to guide drug discovery.  The...

Antibacterial Eliminates Recurrence of C. Difficile Infections in Phase II

Biotechnology
MGB Biopharma has reported positive results from a phase II trial showing that its antibacterial treatment for Clostridium difficile infections cured 100% of...

Biotechnology in Countries Starting with “I” – Part 14: India

Biotechnology
Biotechnology in Countries Starting with “I” – Part 14: India    January 31, 2020    Comments Off on Biotechnology in Countries Starting with...

Chinese Biopharma Startup I-Mab Plans Nasdaq IPO

Startups
I-Mab, a Shanghai-based developer of biologic treatments for cancers and autoimmune disorders, has filed for an IPO on...
1...272829Page 29 of 29

Latest Intelligence

spot_img
spot_img

Copyright @ 2024 Plato Technologies Inc.